Welkos Susan L, Klimko Christopher P, Kern Steven J, Bearss Jeremy J, Bozue Joel A, Bernhards Robert C, Trevino Sylvia R, Waag David M, Amemiya Kei, Worsham Patricia L, Cote Christopher K
Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, Maryland, United States of America.
Biostatisitics Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, Maryland, United States of America.
PLoS One. 2015 Apr 24;10(4):e0124667. doi: 10.1371/journal.pone.0124667. eCollection 2015.
Burkholderia pseudomallei, the etiologic agent of melioidosis, is a gram-negative facultative intracellular bacterium. This bacterium is endemic in Southeast Asia and Northern Australia and can infect humans and animals by several routes. It has also been estimated to present a considerable risk as a potential biothreat agent. There are currently no effective vaccines for B. pseudomallei, and antibiotic treatment can be hampered by nonspecific symptomology, the high incidence of naturally occurring antibiotic resistant strains, and disease chronicity. Accordingly, there is a concerted effort to better characterize B. pseudomallei and its associated disease. Before novel vaccines and therapeutics can be tested in vivo, a well characterized animal model is essential. Previous work has indicated that mice may be a useful animal model. In order to develop standardized animal models of melioidosis, different strains of bacteria must be isolated, propagated, and characterized. Using a murine intraperitoneal (IP) infection model, we tested the virulence of 11 B. pseudomallei strains. The IP route offers a reproducible way to rank virulence that can be readily reproduced by other laboratories. This infection route is also useful in distinguishing significant differences in strain virulence that may be masked by the exquisite susceptibility associated with other routes of infection (e.g., inhalational). Additionally, there were several pathologic lesions observed in mice following IP infection. These included varisized abscesses in the spleen, liver, and haired skin. This model indicated that commonly used laboratory strains of B. pseudomallei (i.e., K96243 and 1026b) were significantly less virulent as compared to more recently acquired clinical isolates. Additionally, we characterized in vitro strain-associated differences in virulence for macrophages and described a potential inverse relationship between virulence in the IP mouse model of some strains and in the macrophage phagocytosis assay. Strains which were more virulent for mice (e.g., HBPU10304a) were often less virulent in the macrophage assays, as determined by several parameters such as intracellular bacterial replication and host cell cytotoxicity.
类鼻疽杆菌是类鼻疽病的病原体,是一种革兰氏阴性兼性胞内细菌。这种细菌在东南亚和澳大利亚北部流行,可通过多种途径感染人类和动物。据估计,它作为一种潜在的生物威胁剂也存在相当大的风险。目前尚无针对类鼻疽杆菌的有效疫苗,非特异性症状、天然存在的抗生素耐药菌株的高发生率以及疾病的慢性化会妨碍抗生素治疗。因此,人们正在齐心协力更好地描述类鼻疽杆菌及其相关疾病。在新型疫苗和治疗方法能够在体内进行测试之前,一个特征明确的动物模型至关重要。先前的研究表明小鼠可能是一种有用的动物模型。为了建立标准化的类鼻疽病动物模型,必须分离、培养和鉴定不同的细菌菌株。我们使用小鼠腹腔内(IP)感染模型,测试了11种类鼻疽杆菌菌株的毒力。腹腔内途径提供了一种可重复的方法来对毒力进行排序,其他实验室可以轻松复制。这种感染途径对于区分可能被其他感染途径(如吸入)相关的高度易感性所掩盖的菌株毒力的显著差异也很有用。此外,在小鼠腹腔内感染后观察到了几种病理病变。这些病变包括脾脏、肝脏和有毛皮肤中大小不一的脓肿。该模型表明,与最近获得的临床分离株相比,常用的类鼻疽杆菌实验室菌株(即K96243和1026b)的毒力明显较低。此外,我们在体外对巨噬细胞的菌株相关毒力差异进行了表征,并描述了某些菌株在IP小鼠模型中的毒力与巨噬细胞吞噬试验中的毒力之间可能存在的反比关系。对小鼠毒力更强的菌株(如HBPU10304a)在巨噬细胞试验中通常毒力较低,这是通过细胞内细菌复制和宿主细胞细胞毒性等几个参数确定的。